Profit Or Loss [Abstract]

BerGenBio - Filing #5877180

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
848,000 NOK
354,000 NOK
Other expenses, by nature
111,020,000 NOK
136,345,000 NOK
Profit (loss) from operating activities
151,234,000 NOK
191,819,000 NOK
Finance income
16,653,000 NOK
13,409,000 NOK
Finance costs
4,700,000 NOK
11,991,000 NOK
Profit (loss) before tax
139,282,000 NOK
190,401,000 NOK
Tax expense (income)
0 NOK
0 NOK
Profit (loss)
139,282,000 NOK
139,282,000 NOK
190,401,000 NOK
190,401,000 NOK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
3.95
0.13
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
3.95
0.13

Talk to a Data Expert

Have a question? We'll get back to you promptly.